S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The 3-Stock Retirement Blueprint (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The 3-Stock Retirement Blueprint (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The 3-Stock Retirement Blueprint (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The 3-Stock Retirement Blueprint (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
MUST WATCH: Unusual 3-second financial maneuver (Ad)
NASDAQ:SILK

Silk Road Medical - SILK Stock Forecast, Price & News

$48.14
-0.24 (-0.50%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$47.29
▼
$48.60
50-Day Range
$33.01
▼
$48.88
52-Week Range
$27.21
▼
$67.49
Volume
182,783 shs
Average Volume
354,758 shs
Market Capitalization
$1.70 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$49.33

Silk Road Medical MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
2.5% Upside
$49.33 Price Target
Short Interest
Bearish
6.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.08mentions of Silk Road Medical in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$4.21 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.81) to ($1.54) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.32 out of 5 stars

Medical Sector

1093rd out of 1,135 stocks

Surgical & Medical Instruments Industry

108th out of 114 stocks

See Top Rated MarketRank™ Stocks Here
SILK stock logo

About Silk Road Medical (NASDAQ:SILK) Stock

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Silk Road Medical Trading Down 0.5 %

SILK opened at $48.14 on Friday. Silk Road Medical has a fifty-two week low of $27.21 and a fifty-two week high of $67.49. The company has a quick ratio of 3.73, a current ratio of 6.92 and a debt-to-equity ratio of 1.23. The company has a fifty day moving average of $40.36 and a two-hundred day moving average of $37.21.

Analysts Set New Price Targets

Several brokerages recently issued reports on SILK. Stifel Nicolaus reduced their target price on shares of Silk Road Medical from $55.00 to $46.00 in a report on Monday, July 18th. Citigroup cut shares of Silk Road Medical from a "neutral" rating to a "sell" rating and set a $33.00 price objective for the company. in a report on Monday, July 11th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, Silk Road Medical currently has an average rating of "Hold" and a consensus target price of $49.33.

Insider Transactions at Silk Road Medical

In other news, CFO Lucas W. Buchanan sold 25,000 shares of the business's stock in a transaction dated Friday, August 12th. The shares were sold at an average price of $47.79, for a total transaction of $1,194,750.00. Following the completion of the sale, the chief financial officer now owns 191,764 shares of the company's stock, valued at $9,164,401.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Lucas W. Buchanan sold 25,000 shares of the business's stock in a transaction dated Friday, August 12th. The shares were sold at an average price of $47.79, for a total transaction of $1,194,750.00. Following the completion of the sale, the chief financial officer now owns 191,764 shares of the company's stock, valued at $9,164,401.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Elizabeth H. Weatherman sold 5,000 shares of the business's stock in a transaction dated Thursday, July 21st. The stock was sold at an average price of $41.91, for a total transaction of $209,550.00. Following the sale, the director now directly owns 229,454 shares of the company's stock, valued at approximately $9,616,417.14. The disclosure for this sale can be found here. Insiders sold 95,000 shares of company stock valued at $4,212,350 over the last 90 days. Corporate insiders own 7.66% of the company's stock.

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Stock News Headlines

August 2, 2022 | marketbeat.com
3 Small Caps With Big Return Potential (SILK)
In a year in which the risk-on trade has been muted, U.S. small cap stocks are holding up relatively well. In fact, the historically more volatile asset class is down approximately 13% year-to-date compared to 15% for U.S. large caps
July 28, 2022 | nasdaq.com
SILK Crosses Above Average Analyst Target
August 14, 2022 | Investing Daily (Ad)
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
July 27, 2022 | finance.yahoo.com
Silk Road Medical's Q2 Margins Hit By Manufacturing Expansion Costs
July 27, 2022 | americanbankingnews.com
Elizabeth H. Weatherman Sells 5,000 Shares of Silk Road Medical, Inc (NASDAQ:SILK) Stock
July 26, 2022 | seekingalpha.com
Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q2 2022 Results - Earnings Call Transcript
July 25, 2022 | msn.com
Earnings Preview: Silk Road Medical
July 22, 2022 | finance.yahoo.com
Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
August 14, 2022 | Investing Daily (Ad)
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
July 20, 2022 | americanbankingnews.com
Silk Road Medical (NASDAQ:SILK) PT Lowered to $46.00
July 19, 2022 | seekingalpha.com
Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture
July 12, 2022 | finance.yahoo.com
Silk Road Medical to Report Second Quarter 2022 Financial Results on July 26, 2022
July 12, 2022 | nasdaq.com
Silk Road Medical Breaks Above 200-Day Moving Average - Bullish for SILK
July 12, 2022 | finance.yahoo.com
Does Silk Road Medical (NASDAQ:SILK) Have A Healthy Balance Sheet?
June 15, 2022 | finance.yahoo.com
Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR
June 9, 2022 | finance.yahoo.com
Despite recent gains, Silk Road Medical, Inc (NASDAQ:SILK) insiders are still down US$8.9k after purchasing last year
June 2, 2022 | finance.yahoo.com
Silk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk Patients
May 31, 2022 | finance.yahoo.com
Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing
May 17, 2022 | seekingalpha.com
Silk Road Medical, Inc 2022 Q1 - Results - Earnings Call Presentation
May 17, 2022 | markets.businessinsider.com
Analyst Ratings for Silk Road Medical
May 10, 2022 | finance.yahoo.com
Investors one-year losses grow to 41% as the stock sheds US$396m this past week
May 4, 2022 | finance.yahoo.com
Silk Road Medical Reports First Quarter 2022 Financial Results
May 3, 2022 | morningstar.com
Silk Road Medical Shares Surge on Expanded Enroute Approval
May 2, 2022 | marketwatch.com
Silk Road Medical Shares Surge on Expanded Enroute Approval >SILK
May 2, 2022 | seekingalpha.com
Silk Road Medical says FDA expanded approval for stent system
May 2, 2022 | finance.yahoo.com
Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System
April 26, 2022 | finance.yahoo.com
Silk Road Medical to Present at the BofA Securities 2022 Healthcare Conference
See More Headlines
Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Company Calendar

Last Earnings
11/09/2021
Today
8/14/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SILK
CUSIP
N/A
CIK
1397702
Web
www.silkroadmed.com
Phone
(408) 720-9002
Fax
408-720-9013
Employees
352
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$49.33
High Stock Price Forecast
$66.00
Low Stock Price Forecast
$33.00
Forecasted Upside/Downside
+2.5%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.74)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-49,810,000.00
Net Margins
-53.13%
Pretax Margin
-53.13%
Return on Equity
-82.20%
Return on Assets
-38.64%

Debt

Debt-to-Equity Ratio
1.23
Current Ratio
6.92
Quick Ratio
3.73

Sales & Book Value

Annual Sales
$101.47 million
Price / Sales
16.72
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.70 per share
Price / Book
28.32

Miscellaneous

Outstanding Shares
35,240,000
Free Float
32,541,000
Market Cap
$1.70 billion
Optionable
Not Optionable
Beta
1.48

Key Executives

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













SILK Stock - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings or view top-rated stocks.

What is Silk Road Medical's stock price forecast for 2022?

5 brokerages have issued 12-month price targets for Silk Road Medical's shares. Their SILK share price forecasts range from $33.00 to $66.00. On average, they anticipate the company's share price to reach $49.33 in the next twelve months. This suggests a possible upside of 2.5% from the stock's current price.
View analysts price targets for SILK or view top-rated stocks among Wall Street analysts.

How have SILK shares performed in 2022?

Silk Road Medical's stock was trading at $42.61 at the start of the year. Since then, SILK stock has increased by 13.0% and is now trading at $48.14.
View the best growth stocks for 2022 here.

When is Silk Road Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our SILK earnings forecast.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings results on Tuesday, November, 9th. The company reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.31) by $0.09. The business earned $24.70 million during the quarter, compared to the consensus estimate of $26.03 million. Silk Road Medical had a negative net margin of 53.13% and a negative trailing twelve-month return on equity of 82.20%. During the same period last year, the company earned ($0.31) earnings per share.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical updated its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of for the period. The company issued revenue guidance of $128.00 million-$133.00 million, compared to the consensus revenue estimate of $129.32 million.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), Honeywell International (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Clearbridge Investments LLC (4.37%), Kayne Anderson Rudnick Investment Management LLC (3.84%), TimesSquare Capital Management LLC (2.43%), Ensign Peak Advisors Inc (1.35%), Jennison Associates LLC (1.28%) and Peregrine Capital Management LLC (1.17%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Lucas W Buchanan, Pincus & Co Warburg and Richard Ruedy.
View institutional ownership trends.

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $48.14.

How much money does Silk Road Medical make?

Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.70 billion and generates $101.47 million in revenue each year. The company earns $-49,810,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis.

How many employees does Silk Road Medical have?

The company employs 352 workers across the globe.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.